Stop Burzynski’s Dangerous Cancer Treatments, Science Advocates tell FDA
July 2, 2014
The Center for Inquiry requested that the Food and Drug Administration reverse its inexplicable decision to green-light the clinical trials of Dr. Stanislaw Burzynski, whose expensive experimental cancer treatments have proven scientifically baseless and dangerous.
“We are frankly stunned to hear that the clinical hold against Dr. Burzynski has been lifted,” writes CFI in its letter. For decades, Dr. Burzynski and the Houston-based Burzynski Research Institute have been trafficking in unproven and scientifically baseless cancer treatments based on compounds known as antineoplastons, derived from human urine, which Burzynski claims — without evidence — can target and destroy cancer cells. He has taken advantage of desperate patients who are at their most vulnerable, and willing to pay any price.
After the death of a six-year-old patient in 2012, the FDA placed a hold on Burzynski’s trials with children, followed by a hold on trials with adults in 2013, prohibiting him from taking on new patients on whom he could experiment and from whom he could extract more money.
Over several decades, his clinic has proven it is unable to properly protect patient rights, adhere to basic ethical or scientific protocols, or even maintain correct patient records. It has also shown it is willing to exploit desperate cancer patients and their families, milking them out of enormous sums of money. But it has yet to show even a shred of evidence that its cancer treatments have any positive effect whatsoever.
“We struggle to see why the FDA continues to enable this deceptive, antiscientific, and unethical medical adventurism and profiteering, even for patients who are terminally ill,” writes CFI. “Given the behavior of Dr. Burzynski and the Burzynski Research Institute over the course of nearly three decades of failed research and trials, and in the face of a complete lack of scientific evidence demonstrating the efficacy of their expensive and dangerous antineoplaston treatment, we find the FDA’s decision perplexing and profoundly disturbing.”
The letter can be downloaded here (PDF): http://bit.ly/LettertoFDA
A further explanation of Burzynski’s treatments, the lack of science behind them, and his run-ins with medical authorities can be found in a feature by Dr. David Gorski in the March-April 2014 issue of Skeptical Inquirer, or at http://bit.ly/GorskiBurzynski